Scholarlink

<p>The rise of multidrug-resistant (MDR) microorganisms, particularly <i>Escherichia coli</i>, poses a significant threat to global public health, necessitating the development of alternative treatments. This study investigates the antibacterial properties of methanolic <i>Punica granatum</i> (pomegranate) leaf extract (MPGL) against MDR <i>E. coli</i> and explores its potential as a source of natural inhibitors for the CTX-M-9 beta-lactamase enzyme, a key contributor to antibiotic resistance. The disc diffusion assay revealed that MPGL exhibited significant antibacterial activity, with the highest inhibition zone of 16.67 ± 0.29&#xa0;mm at 100&#xa0;µg/disc. Additionally, an <i>in silico</i> approach was employed to identify potential inhibitors from <i>P. granatum</i> phytochemicals. Molecular docking studies demonstrated strong binding affinities of Epicatechin, Kaempferol, and Apigenin to the CTX-M-9 beta-lactamase protein (PDB ID: 1YLY), with binding energies of -6.25, -5.23, and − 5.21&#xa0;kcal/mol, respectively. These compounds also showed favorable pharmacokinetic and toxicity profiles in ADMET analysis, indicating their potential as safe and effective therapeutic agents. Molecular dynamics simulations further confirmed the stability of these compounds in complex with the target protein over a 100 ns trajectory, with Epicatechin showing the most stable interactions. The study highlights the promising antibacterial activity of <i>P. granatum</i> leaf extract and identifies Epicatechin, Kaempferol, and Apigenin as potential lead compounds for developing novel therapies against MDR <i>E. coli</i>. These findings underscore the potential of plant-based compounds in combating antibiotic resistance and provide a foundation for further research into phytopharmaceuticals as alternative treatments for bacterial infections.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Punica granatum leaf extract as a natural antibacterial agent explored by experimental and computational methods

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年5月20日

查看全文
  • Faria Tasnim,
  • Md. Eram Hosen,
  • Al Riyad Hasan,
  • Md. Taohid Hasan,
  • Md. Mizanur Rahaman,
  • Md. Motaher Hossain,
  • Md. Abdulla Al Jubayed,
  • Md. Aktaruzzaman,
  • Mansour Altayyar,
  • Endalamaw Yihune,
  • Md. Tarikul Islam,
  • Magdi E. A. Zaki

摘要

The rise of multidrug-resistant (MDR) microorganisms, particularly Escherichia coli, poses a significant threat to global public health, necessitating the development of alternative treatments. This study investigates the antibacterial properties of methanolic Punica granatum (pomegranate) leaf extract (MPGL) against MDR E. coli and explores its potential as a source of natural inhibitors for the CTX-M-9 beta-lactamase enzyme, a key contributor to antibiotic resistance. The disc diffusion assay revealed that MPGL exhibited significant antibacterial activity, with the highest inhibition zone of 16.67 ± 0.29 mm at 100 µg/disc. Additionally, an in silico approach was employed to identify potential inhibitors from P. granatum phytochemicals. Molecular docking studies demonstrated strong binding affinities of Epicatechin, Kaempferol, and Apigenin to the CTX-M-9 beta-lactamase protein (PDB ID: 1YLY), with binding energies of -6.25, -5.23, and − 5.21 kcal/mol, respectively. These compounds also showed favorable pharmacokinetic and toxicity profiles in ADMET analysis, indicating their potential as safe and effective therapeutic agents. Molecular dynamics simulations further confirmed the stability of these compounds in complex with the target protein over a 100 ns trajectory, with Epicatechin showing the most stable interactions. The study highlights the promising antibacterial activity of P. granatum leaf extract and identifies Epicatechin, Kaempferol, and Apigenin as potential lead compounds for developing novel therapies against MDR E. coli. These findings underscore the potential of plant-based compounds in combating antibiotic resistance and provide a foundation for further research into phytopharmaceuticals as alternative treatments for bacterial infections.